WEREWOLF THERAPEUTICS, INC. Notes Payable, Noncurrent
WEREWOLF THERAPEUTICS, INC. (HOWL) had Notes Payable, Noncurrent of $0 as of 2025-12-31, per its S-4 filed 2026-09-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2026-09-22
- 2025-12-31: Notes Payable, Noncurrent $0.00.
- 2025-09-30: Notes Payable, Noncurrent $21.66M.
- 2025-06-30: Notes Payable, Noncurrent $24.70M.
- 2025-03-31: Notes Payable, Noncurrent $26.59M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 S-4 · filed 2026-09-22 |
| 2025-09-30 | $21.66M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $24.70M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $26.59M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $26.09M S-4 · filed 2026-09-22 |
| 2024-09-30 | $25.62M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $25.16M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $27.75M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $32.66M 10-K · filed 2025-03-11 |
| 2023-09-30 | $37.56M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $39.14M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $39.06M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |